Spectrophotometric Determination of Lead - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Spectrophotometric Determination of Lead
The authors developed a reliable spectrophotometric method for determining and measuring trace amounts of lead in various samples.


Pharmaceutical Technology


20. J.C. Gage, "The Determination of Tracs of Lead and Bismuth in Organic Material," The Analyst 83, 672–674 (1958).

21. A. Weber and V. B. Vouk, "The Extraction Constant of Lead Dithizonate," The Analyst 85, 40, 46 (1960).

22. O. B. Mathre and E. B. Sandell, "Lead-Dithizone Equilibria in Water-Carbon Tetrachloride Systems," Talanta 11, 295–314 (1964).

23. R. A. Jones and A. Szutka, "Determination of Microgram Quantitites of Lead by Spectrophotometric Titration with Dithizone," Anal. Chem. 38, 779 –781 (1966).

24. USP–NF, vol. 1 (US Pharmacopeial Convention, Rockville, MD, 2007), pp. 147–148.

What would you do differently? Email your thoughts about this paper to
and we may post them on http://pharmtech.com/.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here